Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
366-01-001.
Association of Oxygen Extraction Fraction in Grey Matter Nuclei with Cognitive Impairment in Cerebral Small Vessel Disease
Impact: Highlights the clinical relevance of elevated deep nuclei OEF in CSVD, linking cerebrovascular metabolic dysfunction to cognitive deterioration. It provides a potential neuroimaging biomarker for early identification of cognitive impairment.
|
||
|
366-01-002.
Voxel-wise oxygen extraction fraction mapping tracks cognition and longitudinal change in cerebral small vessel disease
Impact: Oxygen extraction fraction (OEF) provides a metabolism-sensitive, implementable
MRI metric to assess disease activity and monitor trajectories in CSVD-related
cognitive impairment.
|
||
|
366-01-003.
Subregional Cerebral Blood Flow Alterations and Their Cognitive Relevance in Cerebral Small Vessel Disease: Insights from ASL
Impact: ASL-based subregional CBF mapping
reveals region-specific hyperperfusion linked to cognitive impairment in CSVD.
These findings support quantitative CBF as a potential biomarker for detecting
early cognitive risk and guiding targeted perfusion monitoring in clinical
practice.
|
||
|
366-01-004.
Following the curvature: sulcal versus gyral cortical localization of cerebral microbleeds in Cerebral Amyloid Angiopathy
Impact: Assessment of cerebral microbleed distribution
along the cortex showed sulcal CMB predominance in Cerebral Amyloid Angiopathy,
indicating variations in hemorrhagic vulnerability along the cortex related to
the gyrencephalic structure of the cortex, hinting towards effects of
inflammation and CSF-flow dynamics.
|
||
|
366-01-005.
Transcriptomic Signatures of Gray Matter Volume Loss in Cerebral Small Vessel Disease
Impact: This study uncovers
molecular drivers of WMH-related GMV loss, aiding CSVD mechanism research,
targeted therapy, and early detection.
|
||
|
366-01-006.
Systolic Blood Pressure Time in Target Range and Cerebral Small Vessel Disease
Impact: To investigate the association between SBP-TTR and the risk of CSVD in hypertensive patients, aiming to provide new evidence for assessing the quality of blood pressure management and for the prevention and control of CSVD.
|
||
|
366-01-007.
The Predictive Value of Blood Biomarkers for Recent Small Subcortical Infarction​ in Cerebral Small Vessel Disease​
Impact: The biomarkers monitored in this study may help understand the pathophysiological mechanisms behind RSSI and provide potential targets for early intervention or risk stratification in patients with RSSI.
|
||
|
366-01-008.
Deep Gray Matter Susceptibility Changes in Cerebral Small Vessel Disease: A 7T QSM Study
Impact: These findings establish subregional QSM signatures as
presymptomatic CSVD biomarkers, enabling risk stratification before clinical
symptoms. The demonstrated superiority of combined susceptibility-structural
imaging supports multimodal early detection approaches, potentially opening
therapeutic windows for preventive interventions in high-risk populations.
|
||
|
366-01-009.
Associations of lenticulostriate artery morphology with aging, vascular risk factors, and cognition: a 7T MRI study
Impact: This study highlights potential of 7T TOF MRI to
characterize LSA geometry and its relationship with vascular health and
cognition. Our findings provide early evidence linking LSA geometry alterations
to vascular risk factors and cognition, enhancing our understanding of cSVD.
|
||
|
366-01-010.
Disentangling MRI-derived blood-brain barrier leakage into vascular permeability and surface area
Impact: The conventional MRI-derived blood-brain barrier leakage rate can be
separated into intrinsic vascular permeability and vascular surface area by
combining dynamic contrast-enhanced MRI and vessel architecture imaging. These
components display opposite behavior in brain pathology and aging.
|
||
|
366-01-011.
HIV-Associated Arterial Remodeling Phenotypes Differ Based on Comorbid CSVD Status: ArteryX and iCafe analysis
Impact: HIV-associated cerebrovascular remodeling is strongly modulated by CSVD status. We identify two distinct phenotypes: distal MCA changes in CSVD- subjects and proximal artery changes in CSVD+ subjects, suggesting different injury pathways and highlighting pipeline-specific sensitivity.
|
||
|
366-01-012.
Automated versus Radiologist Assessment of cerebral small vessel disease Biomarkers on Deep Learning-Accelerated 3D MRI
Impact: This accelerated high-resolution MRI protocol reduces scan times by over 50% while maintaining diagnostic quality, enabling efficient clinical adoption with reliable automated quantification of cerebral small vessel disease biomarkers.
|
||
|
366-01-013.
Multimodal Associations among Brain Structure, Radiomics, and Cognition in Cerebral Small Vessel Disease
Impact: Radiomic features,
particularly wavelet_LLL_glcm_Imc2, provide interpretable, high-accuracy
biomarkers for CSVD-related cognitive impairment, supporting early diagnosis,
mechanistic understanding, and personalized clinical decision-making.
|
||
|
366-01-014.
Thalamic subregional volume alterations in metabolic syndrome and their relationships with blood biomarkers and motor functio
Impact: This study demonstrates that metabolic syndrome is linked to selective atrophy of the right lateral geniculate nucleus(LGN), associated with blood biomarkers and motor slowing, suggesting a potential MRI biomarker for early detection of metabolic-related brain alterations.
|
||
|
366-01-015.
The importance of accounting for hormonal fluctuations in neurofluid imaging: BOLD-CSF coupling relates to estradiol levels
Impact: By identifying estrogen-related variations in BOLD-CSF coupling, this study highlights the effect of hormonal fluctuations on neurofluid dynamics. Thereby, this study emphasizes the importance of considering hormonal influences in neurofluid research and their potential role in altered waste clearance.
|
© 2026 International Society for Magnetic Resonance in Medicine